Icon Plc
General ticker "ICLR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $17.5B
Icon Plc does not follow the US Stock Market performance with the rate: -1.4%.
Estimated limits based on current volatility of 1.8%: low 201.10$, high 208.46$
Factors to consider:
- Current price 13.2% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [238.95$, 344.73$]
- 2024-12-30 to 2025-12-30 estimated range: [290.22$, 405.61$]
Financial Metrics affecting the ICLR estimates:
- Positive: Non-GAAP EPS, $ of 12.77 > 2.29
- Positive: 9.05 < Operating profit margin, % of 11.78
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 3.48
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Operating cash flow per share per price, % of 5.15 <= 7.18
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
Short-term ICLR quotes
Long-term ICLR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5,480.83MM | $7,741.39MM | $8,120.18MM |
| Operating Expenses | $4,872.35MM | $6,946.15MM | $7,164.02MM |
| Operating Income | $608.47MM | $795.24MM | $956.15MM |
| Non-Operating Income | $-411.79MM | $-227.39MM | $-331.69MM |
| Interest Expense | $182.42MM | $229.73MM | $336.70MM |
| Income(Loss) | $196.68MM | $567.85MM | $624.47MM |
| Taxes | $43.49MM | $62.55MM | $12.13MM |
| Profit(Loss) | $153.19MM | $505.30MM | $612.34MM |
| Stockholders Equity | $8,066.83MM | $8,497.96MM | $9,240.74MM |
| Inventory | $0.00MM | $7.06MM | $0.00MM |
| Assets | $17,387.09MM | $17,185.28MM | $16,989.86MM |
| Operating Cash Flow | $829.14MM | $563.32MM | $1,161.03MM |
| Capital expenditure | $93.75MM | $142.16MM | $140.69MM |
| Investing Cash Flow | $-6,024.23MM | $-145.87MM | $-226.65MM |
| Financing Cash Flow | $5,114.73MM | $-864.17MM | $-844.04MM |
| Earnings Per Share* | $2.28 | $6.20 | $7.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.